Clinical Overview
Lansoprazole Gastro-Resistant Capsules (15mg) is a substituted benzimidazole proton pump inhibitor on the WHO Model List of Essential Medicines. It suppresses both basal and stimulated gastric acid secretion by blocking H+/K+-ATPase on gastric parietal cells. Indicated for short-term and maintenance treatment of duodenal and benign gastric ulcers, gastroesophageal reflux disease (GERD), erosive esophagitis, and NSAID-induced gastric ulcer prophylaxis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally once daily in the morning, 30 minutes before breakfast with a glass of water. Swallow whole; do not crush or chew microgranules.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Diarrhea, abdominal pain, nausea, constipation, headache, dizziness. Rare/Severe: Microscopic colitis, severe hypomagnesemia, acute interstitial nephritis, and bone fracture risk with long-term use.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
May cause microscopic colitis (watery diarrhea); discontinue if persistent watery diarrhea develops. Caution in severe hepatic impairment (dose reduction advised).
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.